Article

What Ails Drug Supply Chains? A Model for Diagnosis and Suggestions for a Cure

2023-05-01

Abstract excerpt

Drug shortages have been an ongoing problem in many developed countries well before the COVID-19 global pandemic. The literature suggests many reasons for these shortages. We analyze the drug supply chain (DSC) under a deterministic demand scenario, and then under a random demand scenario using a simulation model. The supply chain consists of a manufacturer, distributor, and healthcare providers. Each entity in th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8ffaa816-ac74-52fc-bf0c-949df72e9b0e
DOI: 10.2139/ssrn.4429112

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

What Ails Drug Supply Chains? A Model for Diagnosis and Suggestions for a CureDOI 10.2139/ssrn.4429112Read

Supply Chain Vulnerabilities in First-Line Treatments for Sexually Transmitted Infections: Implications for U.S. Public Health PreparednessSemantic proximity Read

Risk Assessment and Management of Drug Inventory in Hospitals during COVID-19 Pandemic in TaiwanSemantic proximity Read

When Do Drug Shortages Raise Acquisition Costs? Average Duration Effects and Heterogeneous Price Pass-ThroughSemantic proximity Read

Analysis and Solutions for Drug Shortages in Multi-level Medical Institutions in China: References for Developing CountriesSemantic proximity Read

The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?Semantic proximity Read

Process integration models for emerging challenges: Optimal allocation of antivirals under resource constraintsSemantic proximity Read

A Study on the Heterogeneous Effects of China’s Volume- Based Procurement on Gastrointestinal and Metabolic MedicationsSemantic proximity Read

Closing the Loop: An Integrative Framework for Managing Unwanted Pharmaceuticals During COVID-19 and BeyondSemantic proximity Read

A Case of Excessive, Opportunistic Price Increase of a Generic Oncology DrugSemantic proximity Read

Patients' Attitudes towards Switching to National Volume-Based Procurement (NVBP) Drugs -A Qualitative Investigation in Wuhan, ChinaSemantic proximity Read

The Net Financial Benefits of Single Vendor Integrated CDMO and CRO Drug Development ServicesSemantic proximity Read

The Development, Implementation, and Application of a Probabilistic Risk Assessment Framework to Evaluate Supply Chain ShortagesSemantic proximity Read